Logo image
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma
Journal article   Open access   Peer reviewed

Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma

Gulab S Zode, Markus H Kuehn, Darryl Y Nishimura, Charles C Searby, Kabhilan Mohan, Sinisa D Grozdanic, Kevin Bugge, Michael G Anderson, Abbot F Clark, Edwin M Stone, …
The Journal of clinical investigation, Vol.121(9), pp.3542-3553
09/2011
DOI: 10.1172/jci58183
PMCID: PMC3163970
PMID: 21821918
url
https://doi.org/10.1172/jci58183View
Published (Version of record) Open Access

Abstract

Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully understood. Here, we report the development of a transgenic mouse model of POAG caused by the Y437H MYOC mutation; the mice are referred to herein as Tg-MYOC(Y437H) mice. Analysis of adult Tg-MYOC(Y437H) mice, which we showed express human MYOC containing the Y437H mutation within relevant eye tissues, revealed that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion cell death, and axonal degeneration) closely resembling those seen in patients with POAG caused by the Y437H MYOC mutation. Mutant myocilin was not secreted into the aqueous humor but accumulated in the ER of the trabecular meshwork (TM), thereby inducing ER stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, chronic and persistent ER stress was found to be associated with TM cell death and elevation of IOP in Tg-MYOC(Y437H) mice. Reduction of ER stress with a chemical chaperone, phenylbutyric acid (PBA), prevented glaucoma phenotypes in Tg-MYOC(Y437H) mice by promoting the secretion of mutant myocilin in the aqueous humor and by decreasing intracellular accumulation of myocilin in the ER, thus preventing TM cell death. These results demonstrate that ER stress is linked to the pathogenesis of POAG and may be a target for treatment in human patients.
Phenylbutyrates - therapeutic use Cytoskeletal Proteins - genetics Glaucoma, Open-Angle - genetics Humans Stress, Physiological Endoplasmic Reticulum - metabolism Glaucoma, Open-Angle - pathology Endoplasmic Reticulum - pathology Endoplasmic Reticulum - drug effects Phenylbutyrates - pharmacology Eye Proteins - genetics Transgenes Trabecular Meshwork - cytology Glycoproteins - genetics Trabecular Meshwork - pathology Intraocular Pressure Cells, Cultured Glaucoma, Open-Angle - physiopathology Mice, Transgenic Unfolded Protein Response Glaucoma, Open-Angle - drug therapy Phenotype Animals Trabecular Meshwork - metabolism Mice Apoptosis - physiology Mutation

Details

Metrics

Logo image